Lymphogranuloma venereum in Spain, 2005-2015: A literature review

Asunción Diaz1, Marta Ruiz-Algueró1, Victoria Hernando1

  • 1Unidad de Vigilancia del VIH/Sida y Comportamientos de Riesgo, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España.

Medicina Clinica
|September 1, 2018
PubMed

Insights

Lymphogranuloma venereum (LGV) cases increased in Spain among men who have sex with men (MSM) between 2005-2015. Surveillance is crucial for controlling this sexually transmitted infection, particularly in co-infected individuals.

Area of Science:

  • * Infectious Diseases
  • * Public Health
  • * Epidemiology

Background:

  • * Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) that has re-emerged in Europe.
  • * Outbreaks primarily affect men who have sex with men (MSM), with increasing incidence noted since 2003.
  • * LGV became a notifiable disease in Spain in 2015, highlighting its growing public health significance.

Purpose of the Study:

  • * To conduct a comprehensive review of reported Lymphogranuloma venereum cases in Spain.
  • * To analyze the epidemiological and clinical characteristics of LGV cases between 2005 and 2015.
  • * To assess the spread and evolution of LGV within Spain.

Main Methods:

  • * Systematic review of published studies on LGV cases in Spain from 2005 to 2015.
  • * Inclusion criteria focused on studies reporting clinical and epidemiological data.
  • * Data synthesis from fourteen selected studies across seven autonomous regions.

Main Results:

  • * LGV cases predominantly occurred in Spanish men who have sex with men (MSM), aged 30-45, presenting with anorectal syndrome.
  • * The L2 serotype was the most frequently isolated.
  • * Over 60% of MSM cases were co-infected with HIV, and nearly half reported other concurrent STIs.

Conclusions:

  • * LGV has significantly spread across Spain since its initial reporting over a decade ago.
  • * The observed epidemiological and clinical patterns align with those reported in other European countries.
  • * Implementing national surveillance is essential for understanding LGV's magnitude and trajectory, aiding control efforts.